Efficacy and Safety of RESOLUTE Zotarolimus-Eluting Stent in Treatment of Chinese Diabetic Coronary Lesions
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1000 participants.
Also called NCT01747356
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,000 participants
- Registry
-
NCT01747356
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01747356. Allocation not applicable; no masking; primary purpose treatment. Start 2013-02 (registry gives no type); primary completion 2015-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of RESOLUTE Zotarolimus-Eluting Stent in Treatment of Chinese Diabetic Coronary Lesions
- Acronym
- RESOLUTE-DM
- Condition
- Coronary Artery Disease
- Condition
- Diabetes
- Intervention (Device)
- Resolute stent treatment
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
Record details
- Record id
cardio:ct-nct01747356- Content hash
6ec1a84f5a70245ed23382aa12580d15ac550378e34e7f47f2a9cbd7a5c16e6c